Trop-2 Is a Determinant of Breast Cancer Survival
Authors:
Open Access
- 13 May 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e96993
Abstract
Trop-2 is a calcium signal transducer that drives tumor growth. Anti-Trop-2 antibodies with selective reactivity versus Trop-2 maturation stages allowed to identify two different pools of Trop-2, one localized in the cell membrane and one in the cytoplasm. Of note, membrane-localized/functional Trop-2 was found to be differentially associated with determinants of tumor aggressiveness and distinct breast cancer subgroups. These findings candidated Trop-2 states to having an impact on cancer progression. We tested this model in breast cancer. A large, consecutive human breast cancer case series (702 cases; 8 years median follow-up) was analyzed by immunohistochemistry with anti-Trop-2 antibodies with selective reactivity for cytoplasmic-retained versus functional, membrane-associated Trop-2. We show that membrane localization of Trop-2 is an unfavorable prognostic factor for overall survival (1+ versus 0 for all deaths: hazard ratio, 1.63; P = 0.04), whereas intracellular Trop-2 has a favorable impact on prognosis, with an adjusted hazard ratio for all deaths of 0.48 (high versus low; P = 0.003). A corresponding impact of intracellular Trop-2 was found on disease relapse (high versus low: hazard ratio, 0.51; P = 0.004). Altogether, we demonstrate that the Trop-2 activation states are critical determinants of tumor progression and are powerful indicators of breast cancer patients survival.Keywords
This publication has 30 references indexed in Scilit:
- Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast CancerJapanese Journal of Clinical Oncology, 2012
- Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signalingGenes & Development, 2012
- p53 Status Identifies Two Subgroups of Triple-negative Breast Cancers with Distinct Biological FeaturesJapanese Journal of Clinical Oncology, 2011
- An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancerBritish Journal of Cancer, 2010
- Trop‐1 are conserved growth stimulatory molecules that mark early stages of tumor progressionCancer, 2007
- Molecular Subtyping of Breast Cancer from Traditional Tumor Marker Profiles Using Parallel Clustering MethodsClinical Cancer Research, 2006
- Estrogen Receptors: Role in Breast CancerCritical Reviews in Clinical Laboratory Sciences, 2006
- Meta-analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antineoplastic drugsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Cloning of the gene encoding TROP‐2, a cell‐surface glycoprotein expressed by human carcinomasInternational Journal of Cancer, 1995
- Adjusted survival curve estimation using covariatesJournal of Chronic Diseases, 1982